Tuberculosis in Sudan: A study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Sharaf Eldin, Ghada S ^a,b   Fadl Elmula, Imad ^a   Ali, Mohammed S ^a   Ali, Ahmed B ^a   Salih, Abdel Latif G A ^c   Mallard, Kim ^d   Bottomley, Christian ^d   McNerney, Ruth ^d  

^a AL NEELAIN UNIVERSITY   (Sudan)

^b Ministry of Health   (Sudan)

^c Khartoum Teaching Hospital   (Sudan)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENDER; GENOTYPE; HEALTH STATUS; HOSPITAL ADMISSION; HOUSING; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RELAPSE; RISK FACTOR; SPOLIGOTYPING; STRUCTURED QUESTIONNAIRE; SUDAN; TUBERCULOSIS; CLASSIFICATION; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR TYPING; QUESTIONNAIRE;

ADULT; ANTITUBERCULAR AGENTS; DEMOGRAPHY; FEMALE; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; MYCOBACTERIUM TUBERCULOSIS; QUESTIONNAIRES; SUDAN; TUBERCULOSIS;

EID: 80051662124     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-219     Document Type: Article

References (32)

1. The World Factbook. , https://www.cia.gov/library/publications/the-world-factbook/index.html
2. Lewis MP, . ed Ethnologue: Languages of the World. 2009, Dallas, Texas SIL International, Sixteenth, ed.
3. South Sudan chosen as name for new country. , http://www.bbc.co.uk/news/world-africa-12478957
4. World Development Indicators database. , http://ddp-ext.worldbank.org/ext/ddpreports/ViewSharedReport?&CF=&REPORT_ID=9147&REQUEST_TYPE=VIEWADVANCED
5. El-Sony AI, Khamis AH, Enarson DA, Baraka O, Mustafa SA, Bjune G. Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection. Int J Tuberc Lung Dis 2002, 6(12):1058-1066.
6. World Health Organisation Global tuberculosis control:WHO Report 2010. 2010, Geneva, World Health Organisation.
7. Maalaoui N. Strengthening TB Drug Management in the Sudanese National TB Control Program: In-Depth Review of TB Drug Management, Khartoum, November 10-23, 2008. 2009, Arlington, Va.
8. El-Sony AI, Mustafa SA, Khamis AH, Enarson DA, Baraka OZ, Bjune G. The effect of decentralisation on tuberculosis services in three states of Sudan. Int J Tuberc Lung Dis 2003, 7(5):445-450.
9. El-Sony AI. The cost to health services of human immunodeficiency virus (HIV) co-infection among tuberculosis patients in Sudan. Health Policy 2006, 75(3):272-279. 10.1016/j.healthpol.2005.01.006, 16325960.
10. Dorman SE, Chaisson RE. From magic bullets back to the Magic Mountain: the rise of extensively drug-resistant tuberculosis. Nat Med 2007, 13(3):295-298. 10.1038/nm0307-295, 17342143.
11. Resch SC, Salomon JA, Murray M, Weinstein MC. Cost-effectiveness of treating multidrug-resistant tuberculosis. PLoS Med 2006, 3(7):e241. 10.1371/journal.pmed.0030241, 1483913, 16796403.
12. Baghaei P, Tabarsi P, Dorriz D, Marjani M, Shamaei M, Pooramiri MV, Mansouri D, Farnia P, Masjedi M, Velayati A. Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran. Am J Ther 2011, 18(2):e29-34. 10.1097/MJT.0b013e3181c0806d, 20019591.
13. Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, et al. Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia. Int J Tuberc Lung Dis 2007, 11(12):1314-1320.
14. Otto PA, Agid A, Suzan, Mushtaha. MDR-TB is in town; and might be tugging along XDR-TB. Southern Sudan Medical Journal 2009, 2(3):11.
15. Cavanagh P. The sensitivity to streptomycin, PAS and isoniazid of strains of Myco. Tuberculosis isolated from patients in Khartoum and Wad Medani. Tubercle 1965, 46(3):250-255. 10.1016/S0041-3879(65)80018-6, 4955495.
16. El Sony AI, Baraka O, Enarson DA, Bjune G. Tuberculosis control in Sudan against seemingly insurmountable odds. Int J Tuberc Lung Dis 2000, 4(7):657-664.
17. Sharaf-Eldin GS, Saeed NS, Hamid ME, Jordaan AM, Van der Spuy GD, Warren RM, Van Helden PD, Victor TC. Molecular analysis of clinical isolates of Mycobacterium tuberculosis collected from patients with persistent disease in the Khartoum region of Sudan. J Infect 2002, 44(4):244-251. 10.1053/jinf.2001.0992, 12099732.
18. Geonames. , http://www.geonames.org/search.html?q=&country=SD
19. World Health Organisation Guidelines for Surveillance of drug resistance in tuberculosis. 2000, Geneva: WHO, Aziz MA, 2, World Health Organisation.
20. Canetti G, Froman S, Grosset J, Hauduroy P, Langerova M, Mahler HT, Meissner G, Mitchison DA, Sula L. Mycobacteria: Laboratory Methods for Testing Drug Sensitivity and Resistance. Bull World Health Organ 1963, 29:565-578. 2555065, 14102034.
21. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997, 35(4):907-914. 229700, 9157152.
22. Mazars E, Lesjean S, Banuls AL, Gilbert M, Vincent V, Gicquel B, Tibayrenc M, Locht C, Supply P. High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc Natl Acad Sci USA 2001, 98(4):1901-1906. 10.1073/pnas.98.4.1901, 29354, 11172048.
23. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 2006, 44(12):4498-4510. 10.1128/JCM.01392-06, 1698431, 17005759.
24. Mallard K, Sharaf Eldin GS, McNerney R. ScreenTape as a tool for the rapid differentiation of Mycobacterium tuberculosis isolates. J Med Microbiol 2009, 58(Pt 9):1266-1268.
25. World Health Organisation Anti-tuberculosis drug resistance in the world: Report Number 4. The WHO/IUALTD global project on anti-tuberculosis drug resistance surveillance. WHO/CDS/TB/2008394 2008, Geneva: WHO, World Health Organisation.
26. Temple B, Ayakaka I, Ogwang S, Nabanjja H, Kayes S, Nakubulwa S, Worodria W, Levin J, Joloba M, Okwera A, et al. Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. Clin Infect Dis 2008, 47(9):1126-1134. 10.1086/592252, 2883442, 18808360.
27. Traore H, Fissette K, Bastian I, Devleeschouwer M, Portaels F. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int J Tuberc Lung Dis 2000, 4(5):481-484.
28. El-Ansary EH, Mohammed BA, Hamad AR, Karom AG. Brucellosis among animals and human contacts in eastern Sudan. Saudi Med J 2001, 22(7):577-579.
29. Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, et al. Rapid detection of Mycobacterium tuberculosis and rifampin-resistance using on-demand, near patient technology. J Clin Microbiol 2009,
30. World Health Organisation Global tuberculosis control: surveillance, planning, financing. 2008, Geneva: WHO, World Health Organisation.
31. Kremer K, Glynn JR, Lillebaek T, Niemann S, Kurepina NE, Kreiswirth BN, Bifani PJ, van Soolingen D. Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers. J Clin Microbiol 2004, 42(9):4040-4049. 10.1128/JCM.42.9.4040-4049.2004, 516354, 15364987.
32. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002, 8(8):843-849. 2732522, 12141971.